Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia.
SourceAnesthesiology, 96, 6, (2002), pp. 1525-1527
Article / Letter to editor
Display more detailsDisplay less details
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.